Back to 
ROYAL BANK OF CANADA
ROYAL BANK OF CANADA
XLO2 quarters
Position history for ROYAL BANK OF CANADA's holdings in XILIO THERAPEUTICS INC
No. Royal Bank of Canada exited its XLO (Xilio Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 91 shares worth $1,000. Royal Bank of Canada first reported XLO in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$1,000
Total Shares Change
-91
Quarter-by-Quarter History
Other major holders of XLO: VANGUARD CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY